LSV Asset Management Has $285.51 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

LSV Asset Management cut its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 6.1% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 1,054,773 shares of the company’s stock after selling 68,480 shares during the quarter. LSV Asset Management’s holdings in HCA Healthcare were worth $285,506,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Stone House Investment Management LLC acquired a new stake in HCA Healthcare in the third quarter valued at approximately $25,000. Centerpoint Advisors LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter valued at about $27,000. Bruce G. Allen Investments LLC bought a new stake in HCA Healthcare during the 4th quarter worth approximately $28,000. BluePath Capital Management LLC bought a new stake in shares of HCA Healthcare in the third quarter worth $27,000. Finally, Annis Gardner Whiting Capital Advisors LLC bought a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $30,000. Institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

HCA has been the topic of several analyst reports. TD Cowen reduced their target price on HCA Healthcare from $371.00 to $360.00 and set a “buy” rating on the stock in a report on Tuesday, April 30th. Wells Fargo & Company increased their price objective on shares of HCA Healthcare from $303.00 to $315.00 and gave the stock an “equal weight” rating in a research report on Thursday, March 28th. Oppenheimer increased their price target on HCA Healthcare from $330.00 to $345.00 and gave the stock an “outperform” rating in a report on Monday, April 29th. Deutsche Bank Aktiengesellschaft upped their target price on HCA Healthcare from $330.00 to $359.00 and gave the company a “buy” rating in a research report on Friday, April 12th. Finally, StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Thursday. Four research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $316.59.

Insider Buying and Selling

In other HCA Healthcare news, SVP Chad J. Wasserman sold 344 shares of the stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $321.97, for a total transaction of $110,757.68. Following the completion of the transaction, the senior vice president now owns 2,452 shares in the company, valued at $789,470.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, SVP Chad J. Wasserman sold 344 shares of the firm’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $321.97, for a total value of $110,757.68. Following the completion of the transaction, the senior vice president now directly owns 2,452 shares of the company’s stock, valued at approximately $789,470.44. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Kathleen M. Whalen sold 4,262 shares of the firm’s stock in a transaction on Friday, February 9th. The stock was sold at an average price of $306.21, for a total value of $1,305,067.02. Following the completion of the transaction, the senior vice president now directly owns 10,250 shares of the company’s stock, valued at $3,138,652.50. The disclosure for this sale can be found here. In the last 90 days, insiders sold 7,127 shares of company stock valued at $2,218,364. 1.60% of the stock is owned by insiders.

HCA Healthcare Stock Performance

Shares of HCA stock traded down $1.08 during trading on Friday, hitting $307.76. The company’s stock had a trading volume of 1,044,934 shares, compared to its average volume of 1,189,320. The business has a fifty day moving average of $322.22 and a 200-day moving average of $297.73. The company has a market cap of $81.40 billion, a PE ratio of 15.34, a P/E/G ratio of 1.44 and a beta of 1.66. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $335.83. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, topping analysts’ consensus estimates of $5.01 by $0.35. The company had revenue of $17.34 billion for the quarter, compared to the consensus estimate of $16.81 billion. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The firm’s quarterly revenue was up 11.2% on a year-over-year basis. During the same period in the previous year, the firm earned $4.93 EPS. As a group, research analysts anticipate that HCA Healthcare, Inc. will post 20.74 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Friday, June 14th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Friday, June 14th. This represents a $2.64 annualized dividend and a dividend yield of 0.86%. HCA Healthcare’s payout ratio is presently 13.16%.

HCA Healthcare declared that its Board of Directors has approved a stock buyback plan on Tuesday, January 30th that permits the company to repurchase $6.00 billion in shares. This repurchase authorization permits the company to repurchase up to 7.4% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s board of directors believes its shares are undervalued.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.